New Animal Drug Applications; Beta-Aminopropionitrile Fumarate; n

by the Food and Drug Administration on 02/23/2021.

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of seven new animal drug applications (NADAs) for lack of compliance with the reporting requirements in an FDA regulation.

New Animal Drugs; Withdrawal of Approval of New Animal Drug Applications

by the Food and Drug Administration on 02/23/2021.

The Food and Drug Administration (FDA) is withdrawing approval of seven new animal drug applications (NADAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of these applications have repeatedly failed to file required annual reports for the applications.

National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table; Delay of Effective Date

by the Health and Human Services Department on 02/23/2021.

In accordance with the Presidential directive as expressed in the memorandum of January 20, 2021, from the Assistant to the President and Chief of Staff, entitled ``Regulatory Freeze Pending Review,'' this action delays until April 23, 2021, the effective date of the rule entitled ``National Vaccine Injury Compensation Program: Revisions to the...

Suspension of Community Eligibility

by the Federal Emergency Management Agency on 02/23/2021.

This rule identifies communities where the sale of flood insurance has been authorized under the National Flood Insurance Program (NFIP) that are scheduled for suspension on the effective dates listed within this rule because of noncompliance with the floodplain management requirements of the program. If the Federal Emergency Management Agency...

Agency Information Collection Activities; Comment Request; Reaffirmation Agreement

by the Education Department on 02/23/2021.

In accordance with the Paperwork Reduction Act of 1995, ED is proposing an extension without change of a currently approved collection.

Agency Forms Undergoing Paperwork Reduction Act Review

by the Centers for Disease Control and Prevention on 02/23/2021.

Agency Information Collection Activities: Submission for OMB Review; Comment Request

by the Centers for Medicare & Medicaid Services on 02/23/2021.

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including...

Agency Information Collection Activities; Proposed Collection; Comment Request; Shortages Data Collections

by the Food and Drug Administration on 02/23/2021.

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including...

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Experience Reporting for Licensed Biological Products; and General Records

by the Food and Drug Administration on 02/23/2021.

The Food and Drug Administration (FDA or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol, Including During the Public Health Emergency (COVID-19); Guidance for Industry; Availability

by the Food and Drug Administration on 02/23/2021.

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled ``Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol, Including During the Public Health Emergency (COVID-19).'' This guidance is intended to alert pharmaceutical manufacturers and pharmacists in...

Potential Approach for Defining Durations of Use for Medically Important Antimicrobial Drugs Intended for Use In or On Feed: A Concept Paper; Request for Comments; Extension of Comment Period

by the Food and Drug Administration on 02/23/2021.

The Food and Drug Administration (FDA, we, or Agency) is extending the comment period for the notice that appeared in the Federal Register of January 11, 2021. In that notice, FDA requested comments regarding a document entitled ``Potential Approach for Defining Durations of Use for Medically Important Antimicrobial Drugs Intended for Use In or...

National Vaccine Injury Compensation Program; List of Petitions Received

by the Health Resources and Services Administration on 02/23/2021.

HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United...

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

by the National Institutes of Health on 02/23/2021.

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

by the National Institutes of Health on 02/23/2021.

Center for Scientific Review; Notice of Closed Meetings

by the National Institutes of Health on 02/23/2021.

National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

by the National Institutes of Health on 02/23/2021.

Center for Mental Health Services National Advisory Council; Notice of Meeting

by the Substance Abuse and Mental Health Services Administration on 02/23/2021.

Meeting of the Substance Abuse and Mental Health Services Administration's National Advisory Council

by the Substance Abuse and Mental Health Services Administration on 02/23/2021.

Notice is hereby given of the meeting on March 22, 2021, of the Substance Abuse and Mental Health Services Administration's (SAMHSA) National Advisory Council (SAMHSA NAC). The meeting is open to the public and can only be accessed virtually. Agenda with call-in information will be posted on the SAMHSA website prior to the meeting at:...

30-Day Notice of Proposed Information Collection: Mortgagee's Application for Partial Settlement (Multifamily Mortgage)

by the Housing and Urban Development Department on 02/23/2021.

HUD has submitted the proposed information collection requirement described below to the Office of Management and Budget (OMB) for review, in accordance with the Paperwork Reduction Act. The purpose of this notice is to allow for an additional 30 days of public comment.

30-Day Notice of Proposed Information Collection: Office of Housing Counseling-Agency Performance Review

by the Housing and Urban Development Department on 02/23/2021.

HUD has submitted the proposed information collection requirement described below to the Office of Management and Budget (OMB) for review, in accordance with the Paperwork Reduction Act. The purpose of this notice is to allow for an additional 30 days of public comment.